Brent returns to march levels, encouraged by vaccine advances
The price of Brent once again touched March levels driven by advances in the vaccines against Covid-19, with three candidates close to being authorized, and the hope that, thanks to these advances, the recovery of demand could be a reality in 2021. Brent futures due in January reached 46.71 dollars a barrel this morning, the level at which it was trading at the beginning of March, in the midst of the outbreak of the pandemic.
The WTI is also moving at levels close to March after adding gains in recent sessions and is now at around 43.51 dollars.
We will have to wait until next December 1 to find out if this price increase will disrupt the OPEC+ plans to extend production cuts beyond the end of this year due to the poor recovery in demand and the new restrictions to mobility in some countries.
On the other hand, the increases in crude prices are also coinciding with less tension in the United States, where President Donald Trump has finally agreed to facilitate a smooth transition to the new administration of Joe Biden.
Source: Admiral Markets MetaTrader 5. Brent Futures CFD Chart (January). Data range: from October 25, 2019, to November 24, 2020. Prepared on November 24, 2020, at 11:30 am CET. Keep in mind that past returns do not guarantee future returns.
Did you know that with Admiral Markets you can speculate on the price movement of Brent and WTI futures whether they go up or down? This is possible thanks to Contracts for Difference (CFDs). Click on the following banner if you want to open a real trading account and start trading:
INFORMATION ON ANALYTICAL MATERIALS:
The data provided provides additional information on all analyzes, estimates, forecasts, forecasts, market reviews, weekly outlooks or other evaluations or similar information (hereinafter "Analysis") published on the Admiral Markets website. Before making any investment decisions, pay close attention to the following:
1. This is a marketing communication. The content is posted for informational purposes only and should not be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and is not subject to any prohibition on pre-dissemination of investment research.
2. Each investment decision is made by each client alone, while Admiral Markets UK Ltd (Admiral Markets) will not be liable for any loss or damage arising from such a decision, whether based on content or not.
3. In order to protect the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for the prevention and management of conflicts of interest.
4. The analysis is prepared by an independent analyst, Carolina Caro, SEO implementer (hereinafter "Author") based on personal estimates.
5. While all reasonable efforts are made to ensure that all sources of content are reliable and that all information is presented, as much as possible, in an understandable, timely, accurate, and complete manner, Admiral Markets does not guarantee accuracy. or integrity of any information contained in the Analysis.
6. Any past performance or modelling of the financial instruments indicated in the content should not be construed as an express or implied promise, guarantee, or implication of Admiral Markets for any future performance. The value of the financial instrument may rise and fall, and the preservation of the asset's value is not guaranteed.
7. Leveraged products (including contracts for difference) are speculative in nature and may generate profit or loss. Before you start trading, make sure you fully understand the risks.